{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:33:42Z","timestamp":1788244422377,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["No.2022J011370"],"award-info":[{"award-number":["No.2022J011370"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00259-025-07721-1","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:33:55Z","timestamp":1767573235000},"page":"3734-3748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative analysis of 68Ga-FAPI-46 PET\/CT and 18F-FDG PET\/CT in advanced epithelial ovarian cancer: implications for preoperative scoring and treatment planning"],"prefix":"10.1007","volume":"53","author":[{"given":"Meihua","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qionghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2636-9095","authenticated-orcid":false,"given":"Jianfa","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"3","key":"7721_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"5","key":"7721_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/his.14609","volume":"80","author":"WG Mccluggage","year":"2022","unstructured":"Mccluggage WG, Singh N, Gilks CB. Key changes to the world health organization (WHO) classification of female genital tumours introduced in the 5th edition (2020) [J]. Histopathology. 2022;80(5):762\u201378.","journal-title":"Histopathology"},{"issue":"1","key":"7721_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-018-1339-0","volume":"16","author":"A Llueca","year":"2018","unstructured":"Llueca A, Serra A, Rivadulla I, et al. Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index. World J Surg Oncol. 2018;16(1):37.","journal-title":"World J Surg Oncol"},{"issue":"9990","key":"7721_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","volume":"386","author":"S Kehoe","year":"2015","unstructured":"Kehoe S, Hook J, Nankivell M, et al. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial [J]. Lancet (London England). 2015;386(9990):249\u201357.","journal-title":"Lancet (London England)"},{"issue":"10","key":"7721_CR5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant F, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer [J]. N Engl J Med. 2010;363(10):943\u201353.","journal-title":"N Engl J Med"},{"issue":"8","key":"7721_CR6","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1245\/ASO.2006.08.021","volume":"13","author":"A Fagotti","year":"2006","unstructured":"Fagotti A, Ferrandina G, Fanfani F, et al. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol. 2006;13(8):1156\u201361.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"7721_CR7","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","volume":"89","author":"RE Bristow","year":"2000","unstructured":"Bristow RE, Duska LR, Lambrou NC, et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer. 2000;89(7):1532\u201340.","journal-title":"Cancer"},{"issue":"5","key":"7721_CR8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1097\/IGC.0000000000001253","volume":"28","author":"A Llueca","year":"2018","unstructured":"Llueca A, Escrig J. Specific regions, rather than the entire peritoneal carcinosis index, are predictive of complete resection and survival in advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2018;28(5):1054\u20135.","journal-title":"Int J Gynecol Cancer"},{"key":"7721_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis [J]. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res"},{"issue":"2","key":"7721_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/IGC.0000000000001173","volume":"28","author":"M Rosendahl","year":"2018","unstructured":"Rosendahl M, Harter P, Bj\u00f8rn SF, et al. Specific regions, rather than the entire peritoneal carcinosis index, are predictive of complete resection and survival in advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2018;28(2):316\u201322.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"7721_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ygyno.2017.02.020","volume":"145","author":"RS Suidan","year":"2017","unstructured":"Suidan RS, Ramirez PT, Sarasohn DM, et al. A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer. Gynecol Oncol. 2017;145(1):27\u201331.","journal-title":"Gynecol Oncol"},{"key":"7721_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109168","volume":"117","author":"WT Rahman","year":"2019","unstructured":"Rahman WT, Wale DJ, Viglianti BL, et al. The impact of infection and inflammation in oncologic (18)F-FDG PET\/CT imaging. Biomed Pharmacother. 2019;117:109168.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"7721_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0256-4947.75771","volume":"31","author":"A Almuhaideb","year":"2011","unstructured":"Almuhaideb A, Papathanasiou N, Bomanji J. 18F-FDG PET\/CT imaging in oncology. Ann Saudi Med. 2011;31(1):3\u201313.","journal-title":"Ann Saudi Med"},{"issue":"6","key":"7721_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1053\/j.semnuclmed.2019.06.010","volume":"49","author":"J Kemppainen","year":"2019","unstructured":"Kemppainen J, Hynninen J, Virtanen J, et al. PET\/CT for evaluation of ovarian cancer. Semin Nucl Med. 2019;49(6):484\u201392.","journal-title":"Semin Nucl Med"},{"issue":"10","key":"7721_CR15","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1007\/s00259-021-05450-9","volume":"48","author":"RC Delgado Bolton","year":"2021","unstructured":"Delgado Bolton RC, Aide N, Colletti PM, et al. EANM guideline on the role of 2-[(18)F]FDG PET\/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA). Eur J Nucl Med Mol Imaging. 2021;48(10):3286\u2013302.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"32","key":"7721_CR16","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","volume":"37","author":"E Pur\u00e9","year":"2018","unstructured":"Pur\u00e9 E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene. 2018;37(32):4343\u201357.","journal-title":"Oncogene"},{"issue":"3","key":"7721_CR17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","volume":"39","author":"AA Fitzgerald","year":"2020","unstructured":"Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020;39(3):783\u2013803.","journal-title":"Cancer Metastasis Rev"},{"key":"7721_CR18","doi-asserted-by":"crossref","unstructured":"Koustoulidou S, Hoorens MWH, Dalm SU et al. Cancer-Associated fibroblasts as players in cancer development and progression and their role in targeted radionuclide imaging and therapy [J]. Cancers, 2021, 13(5).","DOI":"10.3390\/cancers13051100"},{"issue":"6","key":"7721_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, et al. (68)Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer [J]. Journal of nuclear medicine: official publication. Soc Nuclear Med. 2019;60(6):801\u20135.","journal-title":"Soc Nuclear Med"},{"issue":"12","key":"7721_CR20","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1007\/s00259-021-05378-0","volume":"48","author":"K Dendl","year":"2021","unstructured":"Dendl K, Koerber SA, Finck R, et al. (68)Ga-FAPI-PET\/CT in patients with various gynecological malignancies [J]. Eur J Nucl Med Mol Imaging. 2021;48(12):4089\u2013100.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"7721_CR21","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00259-022-06096-x","volume":"50","author":"S Liu","year":"2023","unstructured":"Liu S, Feng Z, Xu X, et al. Head-to-head comparison of [(18)F]-FDG and [(68) Ga]-DOTA-FAPI-04 PET\/CT for radiological evaluation of platinum-sensitive recurrent ovarian cancer. Eur J Nucl Med Mol Imaging. 2023;50(5):1521\u201331.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"7721_CR22","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1007\/s00259-023-06369-z","volume":"50","author":"J Chen","year":"2023","unstructured":"Chen J, Xu K, Li C, et al. [(68)Ga]Ga-FAPI-04 PET\/CT in the evaluation of epithelial ovarian cancer: comparison with [(18)F]F-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2023;50(13):4064\u201376.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"7721_CR23","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1007\/s00261-024-04469-4","volume":"49","author":"Y Liu","year":"2024","unstructured":"Liu Y, Pan J, Jing F, et al. Comparison of (68)Ga-FAPI-04 and (18)F-FDG PET\/CT in diagnosing ovarian cancer. Abdom Radiol. 2024;49(12):4531\u201342.","journal-title":"Abdom Radiol"},{"issue":"3","key":"7721_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","volume":"133","author":"DG Mutch","year":"2014","unstructured":"Mutch DG, Prat J. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer [J]. Gynecol Oncol. 2014;133(3):401\u20134.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"7721_CR25","first-page":"29","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy Procedures [J]. 1995;221(1):29\u201342.","journal-title":"Peritonectomy Procedures [J]"},{"issue":"6","key":"7721_CR26","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1007\/s00259-020-05146-6","volume":"48","author":"L Zhao","year":"2021","unstructured":"Zhao L, Pang Y, Luo Z, et al. Role of [(68)Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [(18)F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2021;48(6):1944\u201355.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"7721_CR27","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s11307-022-01729-x","volume":"24","author":"U Elboga","year":"2022","unstructured":"Elboga U, Sahin E, Kus T, et al. Comparison of (68)Ga-FAPI PET\/CT and (18)FDG PET\/CT modalities in gastrointestinal system malignancies with peritoneal involvement. Mol Imaging Biol. 2022;24(5):789\u201397.","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"7721_CR28","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s00259-021-05494-x","volume":"49","author":"J Kuten","year":"2022","unstructured":"Kuten J, Levine C, Shamni O, et al. Head-to-head comparison of [(68)Ga]Ga-FAPI-04 and [(18)F]-FDG PET\/CT in evaluating the extent of disease in gastric adenocarcinoma. Eur J Nucl Med Mol Imaging. 2022;49(2):743\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"7721_CR29","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1007\/s00259-022-05839-0","volume":"49","author":"H K\u00f6mek","year":"2022","unstructured":"K\u00f6mek H, Can C, Kaplan \u0130, et al. Comparison of [(68) Ga]Ga-DOTA-FAPI-04 PET\/CT and [(18)F]FDG PET\/CT in colorectal cancer. Eur J Nucl Med Mol Imaging. 2022;49(11):3898\u2013909.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"7721_CR30","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, et al. A tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med. 2018;59(9):1423\u20139.","journal-title":"J Nucl Med"},{"key":"7721_CR31","doi-asserted-by":"crossref","unstructured":"Hamson EJ, Keane FM, Tholen S et al. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy [J]. Proteomics Clinical applications, 2014, 8(5\u20136): 454\u2009\u2013\u200963.","DOI":"10.1002\/prca.201300095"},{"issue":"8","key":"7721_CR32","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, et al. Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47(8):1820\u201332.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"7721_CR33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2967\/jnumed.122.264689","volume":"64","author":"N Hirmas","year":"2023","unstructured":"Hirmas N, Hamacher R, Sraieb M, et al. Fibroblast-activation protein PET and histopathology in a single-center database of 324 patients and 21 tumor entities. J Nucl Med. 2023;64(5):711\u20136.","journal-title":"J Nucl Med"},{"issue":"1","key":"7721_CR34","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","volume":"114","author":"DS Chi","year":"2009","unstructured":"Chi DS, Eisenhauer EL, Zivanovic O, et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol. 2009;114(1):26\u201331.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"7721_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","volume":"107","author":"GD Aletti","year":"2006","unstructured":"Aletti GD, Dowdy SC, Gostout BS, et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol. 2006;107(1):77\u201385.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"7721_CR36","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1007\/s00259-020-05055-8","volume":"48","author":"S Serfling","year":"2021","unstructured":"Serfling S, Zhi Y, Schirbel A, et al. Improved cancer detection in Waldeyer\u2019s tonsillar ring by (68)Ga-FAPI PET\/CT imaging. Eur J Nucl Med Mol Imaging. 2021;48(4):1178\u201387.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"7721_CR37","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1007\/s00259-023-06235-y","volume":"50","author":"Y Xi","year":"2023","unstructured":"Xi Y, Sun L, Che X, et al. A comparative study of [(68)Ga]Ga-FAPI-04 PET\/MR and [(18)F]FDG PET\/CT in the diagnostic accuracy and resectability prediction of ovarian cancer. Eur J Nucl Med Mol Imaging. 2023;50(9):2885\u201398.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"7721_CR38","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.ejrad.2011.01.112","volume":"81","author":"Y Yuan","year":"2012","unstructured":"Yuan Y, Gu ZX, Tao XF, et al. Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography\/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: a meta-analysis. Eur J Radiol. 2012;81(5):1002\u20136.","journal-title":"Eur J Radiol"},{"key":"7721_CR39","doi-asserted-by":"publisher","unstructured":"Mimoun C, Rouzier R, Benifla JL, et al. Preoperative CT or PET\/CT to assess pelvic and para-aortic lymph node status in epithelial ovarian cancer? A systematic review and meta-analysis. Diagnostics (Basel, Switzerland). 2021. https:\/\/doi.org\/10.3390\/diagnostics11101748.","DOI":"10.3390\/diagnostics11101748"},{"issue":"2","key":"7721_CR40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/RLU.0000000000004505","volume":"48","author":"S Wegen","year":"2023","unstructured":"Wegen S, Roth KS, Weindler J, et al. First clinical experience with [68Ga]Ga-FAPI-46-PET\/CT versus [18F]F-FDG PET\/CT for nodal staging in cervical cancer. Clin Nucl Med. 2023;48(2):150\u20135.","journal-title":"Clin Nucl Med"},{"issue":"6","key":"7721_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/ar2080","volume":"8","author":"S Bauer","year":"2006","unstructured":"Bauer S, Jendro MC, Wadle A, et al. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther. 2006;8(6):R171.","journal-title":"Arthritis Res Ther"},{"issue":"18","key":"7721_CR42","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","volume":"87","author":"P Garin-Chesa","year":"1990","unstructured":"Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci U S A. 1990;87(18):7235\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"7721_CR43","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/RLU.0000000000004192","volume":"47","author":"S Wang","year":"2022","unstructured":"Wang S, Huang Q, Dong K, et al. Double trap escape: omental nodular hyperplasia misdiagnosed as metastasis by 18F-FDG PET\/CT and 68Ga-FAPI PET\/MRI in a patient with gastric adenocarcinoma. Clin Nucl Med. 2022;47(6):551\u20132.","journal-title":"Clin Nucl Med"},{"issue":"25","key":"7721_CR44","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1200\/JCO.22.02765","volume":"41","author":"RE Bristow","year":"2023","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A Meta-Analysis [J]. J Clin Oncology: Official J Am Soc Clin Oncol. 2023;41(25):4065\u201376.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"6","key":"7721_CR45","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A Du Bois","year":"2009","unstructured":"Du Bois A, Reuss A, Pujade-Lauraine E, et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the arbeitsgemeinschaft gynaekologische onkologie studiengruppe ovarialkarzinom (AGO-OVAR) and the groupe d\u2019investigateurs Nationaux pour les etudes des cancers de l\u2019ovaire (GINECO) [J]. Cancer. 2009;115(6):1234\u201344.","journal-title":"Cancer"},{"key":"7721_CR46","doi-asserted-by":"crossref","unstructured":"Rutten MJ, Sonke GS, Westermann AM et al. Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer [J]. Obstetrics and gynecology international, 2015, 2015: 464123.","DOI":"10.1155\/2015\/464123"},{"issue":"2","key":"7721_CR47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ygyno.2017.11.018","volume":"148","author":"CA Hamilton","year":"2018","unstructured":"Hamilton CA, Miller A, Casablanca Y, et al. Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology\/Gynecologic Oncology Group ancillary data study. Gynecol Oncol. 2018;148(2):275\u201380.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"7721_CR48","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e65","volume":"29","author":"Z Feng","year":"2018","unstructured":"Feng Z, Wen H, Jiang Z, et al. A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study. J Gynecol Oncol. 2018;29(5):e65.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"7721_CR49","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ygyno.2019.04.011","volume":"154","author":"A Kumar","year":"2019","unstructured":"Kumar A, Sheedy S, Kim B, et al. Models to predict outcomes after primary debulking surgery: independent validation of models to predict suboptimal cytoreduction and gross residual disease. Gynecol Oncol. 2019;154(1):72\u20136.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"7721_CR50","doi-asserted-by":"publisher","first-page":"743","DOI":"10.21037\/qims.2020.02.19","volume":"10","author":"B Gu","year":"2020","unstructured":"Gu B, Xia L, Ge H, et al. Preoperative PET\/CT score can predict complete resection in advanced epithelial ovarian cancer: a prospective study. Quant Imaging Med Surg. 2020;10(3):743\u201353.","journal-title":"Quant Imaging Med Surg"},{"issue":"4","key":"7721_CR51","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1007\/s00330-021-08305-x","volume":"32","author":"A Glickman","year":"2022","unstructured":"Glickman A, Paredes P, Carreras-Di\u00e9guez N, et al. Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [(18)F]FDG PET\/CT volumetric parameters and tumour markers HE4 and CA125. Eur Radiol. 2022;32(4):2200\u20138.","journal-title":"Eur Radiol"},{"issue":"10","key":"7721_CR52","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1007\/s00259-014-2803-x","volume":"41","author":"JW Lee","year":"2014","unstructured":"Lee JW, Cho A, Lee JH, et al. The role of metabolic tumor volume and total lesion Glycolysis on \u00b9\u2078F-FDG PET\/CT in the prognosis of epithelial ovarian cancer [J]. Eur J Nucl Med Mol Imaging. 2014;41(10):1898\u2013906.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"7721_CR53","first-page":"1519","volume":"45","author":"R Boellaard","year":"2004","unstructured":"Boellaard R, Krak NC, Hoekstra OS, et al. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study [J]. Journal of nuclear medicine: official publication. Soc Nuclear Med. 2004;45(9):1519\u201327.","journal-title":"Soc Nuclear Med"},{"issue":"3","key":"7721_CR54","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00259-006-0224-1","volume":"34","author":"M Westerterp","year":"2007","unstructured":"Westerterp M, Pruim J, Oyen W, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging. 2007;34(3):392\u2013404.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"7721_CR55","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejso.2017.11.003","volume":"44","author":"A Llueca","year":"2018","unstructured":"Llueca A, Escrig J. Prognostic value of peritoneal cancer index in primary advanced ovarian cancer [J]. Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2018;44(1):163\u20139.","journal-title":"Eur J Surg Oncology: J Eur Soc Surg Oncol Br Association Surg Oncol"},{"issue":"4","key":"7721_CR56","doi-asserted-by":"publisher","first-page":"983","DOI":"10.7150\/jca.32317","volume":"11","author":"M Zhou","year":"2020","unstructured":"Zhou M, Wang D, Long Z. Role of laparotomy-based parameters in assessment of optimal primary debulking surgery and long-term outcomes in patients with stage IIIC epithelial ovarian cancer. J Cancer. 2020;11(4):983\u20139.","journal-title":"J Cancer"},{"issue":"5","key":"7721_CR57","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.21873\/anticanres.15732","volume":"42","author":"M Asp","year":"2022","unstructured":"Asp M, Malander S, Bengtsson J. Prognostic value of peritoneal cancer index after complete cytoreductive surgery in advanced ovarian cancer. Anticancer Res. 2022;42(5):2541\u201351.","journal-title":"Anticancer Res"},{"key":"7721_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1421828","volume":"14","author":"S Wang","year":"2024","unstructured":"Wang S, Liu S, Liu F. Does a high peritoneal cancer index lead to a worse prognosis of patients with advanced ovarian cancer?: a systematic review and meta-analysis based on the latest evidence. Front Oncol. 2024;14:1421828.","journal-title":"Front Oncol"},{"issue":"8","key":"7721_CR59","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/RLU.0b013e318299609f","volume":"38","author":"MC Chang","year":"2013","unstructured":"Chang MC, Chen JH, Liang JA. PET or PET\/CT for detection of peritoneal carcinomatosis: a meta-analysis. Clin Nucl Med. 2013;38(8):623\u20139.","journal-title":"Clin Nucl Med"},{"issue":"10","key":"7721_CR60","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00259-004-1577-y","volume":"31","author":"A Suzuki","year":"2004","unstructured":"Suzuki A, Kawano T, Takahashi N. Value of 18F-FDG PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imaging. 2004;31(10):1413\u201320.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1081","key":"7721_CR61","doi-asserted-by":"publisher","first-page":"20170519","DOI":"10.1259\/bjr.20170519","volume":"91","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Lee SW. Diagnostic accuracy of (18)F-FDG PET\/CT for detection of peritoneal carcinomatosis; a systematic review and meta-analysis [J]. Br J Radiol. 2018;91(1081):20170519.","journal-title":"Br J Radiol"},{"issue":"8","key":"7721_CR62","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.21037\/qims-20-784","volume":"11","author":"Z Feng","year":"2021","unstructured":"Feng Z, Liu S, Ju X. Diagnostic accuracy of 18F-FDG PET\/CT scan for peritoneal metastases in advanced ovarian cancer. Quant Imaging Med Surg. 2021;11(8):3392\u20138.","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"7721_CR63","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00259-020-04940-6","volume":"48","author":"H Chen","year":"2021","unstructured":"Chen H, Zhao L, Ruan D, et al. Usefulness of [(68)Ga]Ga-DOTA-FAPI-04 PET\/CT in patients presenting with inconclusive [(18)F]FDG PET\/CT findings. Eur J Nucl Med Mol Imaging. 2021;48(1):73\u201386.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07721-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07721-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07721-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T08:03:03Z","timestamp":1777276983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07721-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["7721"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07721-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"26 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent to publish"}},{"value":"All procedures involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any experiments with animals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}},{"value":"We declare that this manuscript is original, has not been published before and is not currently being considered for publication elsewhere.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Statement"}}]}}